Growing community of inventors

Utrecht, Netherlands

Andreas Hollenstein

Average Co-Inventor Count = 12.00

ph-index = 3

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 13

Andreas HollensteinPaul Parren (4 patents)Andreas HollensteinFrank Beurskens (4 patents)Andreas HollensteinEsther Breij (4 patents)Andreas HollensteinMarije Overdijk (4 patents)Andreas HollensteinSimone Oostindie (4 patents)Andreas HollensteinHilma Van Der Horst (4 patents)Andreas HollensteinMartine E D Chamuleau (4 patents)Andreas HollensteinTuna Mutis (4 patents)Andreas HollensteinEdward Norbert Van Den Brink (3 patents)Andreas HollensteinRonald P Taylor (3 patents)Andreas HollensteinMargaret A Lindorfer (3 patents)Andreas HollensteinRonald Taylor (1 patent)Andreas HollensteinAndreas Hollenstein (4 patents)Paul ParrenPaul Parren (127 patents)Frank BeurskensFrank Beurskens (13 patents)Esther BreijEsther Breij (12 patents)Marije OverdijkMarije Overdijk (9 patents)Simone OostindieSimone Oostindie (7 patents)Hilma Van Der HorstHilma Van Der Horst (5 patents)Martine E D ChamuleauMartine E D Chamuleau (5 patents)Tuna MutisTuna Mutis (5 patents)Edward Norbert Van Den BrinkEdward Norbert Van Den Brink (54 patents)Ronald P TaylorRonald P Taylor (15 patents)Margaret A LindorferMargaret A Lindorfer (10 patents)Ronald TaylorRonald Taylor (1 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Genmab Holding B.v. (4 from 5 patents)


4 patents:

1. 12448459 - Bispecific anti-CD37 antibodies, monoclonal anti-CD37 antibodies and methods of use thereof

2. 11512137 - Bispecific anti-CD37 antibodies, monoclonal anti-CD37 antibodies and methods of use thereof

3. 11396553 - Bispecific anti-CD37 antibodies, monoclonal anti-CD37 antibodies and methods of use thereof

4. 11034772 - Bispecific anti-CD37 antibodies, monoclonal anti-CD37 antibodies and methods of use thereof

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/6/2025
Loading…